Abbisko Cayman Limited (2256.HK)
HKD 7.83
(-6.23%)
HKD 7.83
(-6.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 35.72 Million CNY | -21.61% |
| 2022 | 45.57 Million CNY | -15.29% |
| 2021 | 53.8 Million CNY | 1149.51% |
| 2020 | 4.3 Million CNY | -51.62% |
| 2019 | 8.9 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2024 Q1 | - CNY | -100.0% |
| 2023 FY | 35.72 Million CNY | -21.61% |
| 2023 Q2 | 40.77 Million CNY | 33.49% |
| 2023 Q1 | 30.54 Million CNY | -32.98% |
| 2023 Q4 | 35.72 Million CNY | 42.25% |
| 2023 Q3 | 25.11 Million CNY | -38.41% |
| 2022 Q2 | 51.73 Million CNY | 28.31% |
| 2022 Q1 | 40.31 Million CNY | -10.29% |
| 2022 FY | 45.57 Million CNY | -15.29% |
| 2022 Q4 | 45.57 Million CNY | 27.99% |
| 2022 Q3 | 35.6 Million CNY | -31.17% |
| 2021 Q2 | - CNY | -100.0% |
| 2021 FY | 53.8 Million CNY | 1149.51% |
| 2021 Q1 | 4.34 Million CNY | 0.0% |
| 2021 Q4 | 44.94 Million CNY | 0.0% |
| 2021 Q3 | 44.94 Million CNY | 0.0% |
| 2020 FY | 4.3 Million CNY | -51.62% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 8.9 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | 32.427% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 99.398% |